Edition:
India

Clearside Biomedical Inc (CLSD.OQ)

CLSD.OQ on NASDAQ Stock Exchange Global Market

6.34USD
11:23pm IST
Change (% chg)

$0.12 (+1.93%)
Prev Close
$6.22
Open
$6.19
Day's High
$6.36
Day's Low
$6.13
Volume
19,421
Avg. Vol
50,865
52-wk High
$10.31
52-wk Low
$5.44

Select another date:

Wed, Nov 8 2017

BRIEF-Clearside Biomedical Q3 loss per share $0.72

* Clearside Biomedical, Inc. Announces third quarter 2017 financial results and provides corporate update

BRIEF-Clearside Biomedical announces completion of patient enrollment in phase 2 clinical trial of CLS-TA

* Clearside Biomedical announces completion of patient enrollment in phase 2 clinical trial of CLS-TA used together with Eylea in patients with diabetic macular edema

BRIEF-Clearside Biomedical reports Q2 loss per share $0.54

* Announces second quarter 2017 financial results and provides corporate update

BRIEF-Clearside Biomedical completes patient enrollment in Phase 3 Peachtree Clinical Trial of CLS-TA

* Announces completion of patient enrollment in pivotal Phase 3 Peachtree Clinical Trial of CLS-TA for Suprachoroidal administration in patients with Macular Edema associated with non-infectious Uveitis

Select another date: